Dar Zavain has filed 21 insider transactions across 1 company since April 2023.
Most recent transaction: a grant/award of 4902 shares of RECURSION PHARMACEUTICALS, INC. ($RXRX) on April 01, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 4902 | $0.00 | 147,231.0000 | 514,895,802 | 3.44% | 0.00% |
| Jan. 2, 2026 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 3571 | $0.00 | 142,329.0000 | 514,895,802 | 2.57% | 0.00% |
| Oct. 1, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 2941 | $0.00 | 138,758.0000 | 395,072,094 | 2.17% | 0.00% |
| July 1, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 2924 | $0.00 | 135,817.0000 | 395,072,094 | 2.20% | 0.00% |
| June 18, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 22016 | $0.00 | 132,893.0000 | 395,072,094 | 19.86% | 0.01% |
| June 18, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Stock Option (Right to Buy) | 44031 | $0.00 | 44,031.0000 | 395,072,094 | 9999.99% | 0.01% |
| April 1, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 2745 | $0.00 | 110,877.0000 | 395,072,094 | 2.54% | 0.00% |
| Jan. 2, 2025 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 1907 | $0.00 | 108,132.0000 | 0 | 1.80% | 0.00% |
| Oct. 1, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 2229 | $0.00 | 106,225.0000 | 0 | 2.14% | 0.00% |
| July 1, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 1843 | $0.00 | 103,996.0000 | 0 | 1.80% | 0.00% |
| June 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Stock Option (Right to Buy) | 26193 | $0.00 | 26,193.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 13097 | $0.00 | 102,153.0000 | 0 | 14.71% | 0.00% |
| April 1, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 1467 | $0.00 | 89,056.0000 | 0 | 1.67% | 0.00% |
| Jan. 2, 2024 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 1393 | $0.00 | 55,216.0000 | 0 | 2.59% | 0.00% |
| Dec. 14, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | S | Class A Common Stock | 20141 | $9.00 | 53,823.0000 | 0 | 27.23% | 0.00% |
| Oct. 2, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 1920 | $0.00 | 73,964.0000 | 0 | 2.67% | 0.00% |
| July 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 1863 | $0.00 | 72,044.0000 | 0 | 2.65% | 0.00% |
| June 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 12612 | $0.00 | 70,181.0000 | 0 | 21.91% | 0.00% |
| June 16, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Stock Option (Right to Buy) | 25224 | $0.00 | 61,514.0000 | 0 | 69.51% | 0.00% |
| April 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 1996 | $0.00 | 57,569.0000 | 0 | 3.59% | 0.00% |
| April 3, 2023 | RECURSION PHARMACEUTICALS, INC. | $RXRX | Dar Zavain | Director | A | Class A Common Stock | 1996 | $0.00 | 22,561.0000 | 0 | 9.71% | 0.00% |